ACTIVE

NewMilkLab

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

145 k €

-0.7% YoY

Gross margin

2,4 M €

-5.2% YoY

Equity

497,7 k €

+41.1% YoY

Workforce

21,4 ETP

-13.7% YoY

What does NewMilkLab do?

NewMilkLab is a Public limited company incorporated in 2008. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 21,4 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0896.615.540

Incorporation

20/03/2008

Legal form

Public limited company

Registered office

Technologiepark-Zwijnaarde 82
9052 Gent · FlandreSee on map

Contributed capital

61 500,00 €

Latest accounts

31/12/2025

Average workforce

21,4 ETP

Activities (NACE)

72101Research and experimental development on natural sciences and engineering· main 72110Research and experimental development on biotechnology

Joint committees (1)

Signals

ProfitablePositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 16 financial years

	2025		2024		2023		2022		2021		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Gross margin	2,4 M €	-5.2%	2,5 M €	+11.5%	2,2 M €	+23.0%	1,8 M €	+29.4%	1,4 M €	-36.6%	2,2 M €	-24.5%	2,9 M €	-6.2%	3,1 M €	-6.3%	3,3 M €	+1.7%	3,3 M €	-0.3%	3,3 M €	+6.4%	3,1 M €	+62.7%	1,9 M €	+42.9%	1,3 M €	+39.7%	954,9 k €	+91.2%	499,3 k €
EBITDA	298,5 k €	+8.6%	274,8 k €	+39.4%	197,1 k €	+19.3%	165,2 k €	+69.9%	97,3 k €	-58.2%	233 k €	-43.0%	408,8 k €	-37.0%	649,3 k €	-13.0%	746,5 k €	+4.1%	717,3 k €	-13.5%	829,4 k €	+3.0%	805,5 k €	+129%	352,4 k €	+55.5%	226,6 k €	+86.5%	121,5 k €	+42.6%	85,2 k €
Operating result	146,7 k €	+0.4%	146,1 k €	+24.3%	117,5 k €	+17.8%	99,7 k €	+35.8%	73,4 k €	-21.5%	93,6 k €	-48.7%	182,6 k €	-1.5%	185,3 k €	-13.5%	214,2 k €	+14.6%	186,9 k €	-50.0%	374 k €	+13.8%	328,6 k €	+162%	125,4 k €	+60.7%	78 k €	+22.7%	63,6 k €	+119%	29,1 k €
Net result	145 k €	-0.7%	146 k €	+25.0%	116,8 k €	+21.0%	96,5 k €	+32.1%	73,1 k €	-19.7%	91 k €	-50.0%	181,9 k €	-1.3%	184,2 k €	-13.0%	211,7 k €	+5.3%	201,1 k €	-42.4%	349,2 k €	+10.6%	315,8 k €	+162%	120,6 k €	+59.4%	75,6 k €	+48.3%	51 k €	+75.6%	29,1 k €
Balance sheet
Equity	497,7 k €	+41.1%	352,7 k €	+70.6%	206,7 k €	+130%	89,9 k €	+1452%	-6,6 k €	-100%	1,9 M €	+5.1%	1,8 M €	+11.4%	1,6 M €	+13.0%	1,4 M €	+17.6%	1,2 M €	+20.1%	1 M €	+53.4%	653,6 k €	+93.5%	337,8 k €	+55.5%	217,2 k €	+53.4%	141,6 k €	+56.3%	90,6 k €
Total assets	2,3 M €	-7.3%	2,5 M €	+46.6%	1,7 M €	+83.0%	934,8 k €	+127%	412,2 k €	-82.4%	2,3 M €	-8.1%	2,6 M €	+19.5%	2,1 M €	-12.6%	2,4 M €	+30.7%	1,9 M €	-16.3%	2,2 M €	-0.3%	2,2 M €	+72.4%	1,3 M €	-39.3%	2,1 M €	+57.1%	1,4 M €	+37.1%	994,7 k €
Cash	386,1 k €	+22.5%	315,2 k €	+15.2%	273,5 k €	+0.4%	272,5 k €	+307%	66,9 k €	+106%	32,4 k €	-39.7%	53,8 k €	-32.2%	79,3 k €	-59.3%	195,1 k €	-56.5%	448,6 k €	+523%	72 k €	+7.5%	67 k €	-63.5%	183,5 k €	+42.9%	128,4 k €	+99.9%	64,2 k €	+1235%	4,8 k €
Debts	1,8 M €	-15.1%	2,1 M €	+42.5%	1,5 M €	+80.1%	819,2 k €	+108%	394 k €	-12.9%	452,5 k €	-40.5%	760,9 k €	+44.1%	528,1 k €	-48.6%	1 M €	+54.3%	666,1 k €	-45.9%	1,2 M €	-22.4%	1,6 M €	+65.0%	962,1 k €	-50.0%	1,9 M €	+60.5%	1,2 M €	+36.1%	881,7 k €
Other
Workforce	21,4 ETP	-13.7%	24,8 ETP	+3.3%	24,0 ETP	+12.7%	21,3 ETP	+19.0%	17,9 ETP	-26.6%	24,4 ETP	-22.3%	31,4 ETP	-5.4%	33,2 ETP	-1.2%	33,6 ETP	-2.9%	34,6 ETP	+0.6%	34,4 ETP	+15.8%	29,7 ETP	+41.4%	21,0 ETP	+45.8%	14,4 ETP	+53.2%	9,4 ETP	+49.2%	6,3 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 41 ended

Active mandates

Hille Van der Kaa

Director · since 25 juin 2025 · until 05 mars 2031

Active

Jacob Korteweg

Director · since 25 juin 2025 · until 05 mars 2031

Active

Niko Koffeman

Director · since 25 juin 2025 · until 05 mars 2031

Active

Ended mandates

Hille Van der Kaa

Director · since 20 mars 2020 · until 31 mars 2025

Ended

Hille Van der Kaa

Director · since 20 mars 2020 · until 06 juin 2025

Ended

Jacob Korteweg

Director · since 20 mars 2020 · until 31 mars 2025

Ended

Jacob Korteweg

Director · since 20 mars 2020 · until 06 juin 2025

Ended

At this address

Other companies at this address

Company	CBE no.
Amalus Therapeutics● Bankrupt	0803.929.268
APCOR R&M● Active	0600.952.909
Ardoyen● Active	0875.102.821
AVROXA● Active	0687.774.936
Benebiose● Active	0784.521.548
BioNeering● Active	0807.194.309
CONTREL EUROPE● Active	0426.204.637
CRODEON TECHNOLOGIES● Active	0642.754.761
Cryptobiotix● Active	0762.565.104
Gulliver Biomed● Active	0692.527.837
ImplicitMeasures.com● Bankrupt	0657.989.701
Inbiose● Active	0534.887.593
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT● Active	0440.054.752
INNOVATIVE PHARMACEUTICS● Active	0883.574.582
Inspect● Active	0645.950.417
INVIBES ADVERTISING● Active	0836.533.938
KYTOS● Active	0768.755.286
Lares Solutions● Active	1015.346.906
MAYAKU PHARMACEUTICAL DEVELOPMENT● Active	0755.350.975
Microbial Resource Management Health● Active	0742.910.132

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/04/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	9 months
Filing date	05/08/2026	30/07/2025	28/08/2024	16/06/2023	08/04/2022	16/06/2021
General meeting	29/07/2026	25/06/2025	28/06/2024	01/03/2023	02/03/2022	03/03/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/07/2026	05/08/2026	Dutch	PDF
Abridged model	31/12/2024	25/06/2025	30/07/2025	Dutch	PDF
Abridged model	31/12/2023	28/06/2024	28/08/2024	Dutch	PDF
Abridged model	31/12/2022	01/03/2023	16/06/2023	Dutch	PDF
Abridged model	31/12/2021	02/03/2022	08/04/2022	Dutch	PDF
Abridged model	31/12/2020	03/03/2021	16/06/2021	Dutch	PDF
Abridged model	31/03/2020	02/07/2020	30/10/2020	Dutch	PDF
Abridged model	31/03/2019	04/07/2019	01/10/2019	Dutch	PDF
Abridged model	31/03/2018	05/07/2018	24/09/2018	Dutch	PDF
Abridged model	31/03/2017	06/07/2017	29/09/2017	Dutch	PDF
Abridged model	31/03/2016	26/05/2016	12/08/2016	Dutch	PDF
Abridged model	31/03/2015	02/07/2015	17/09/2015	Dutch	PDF
Abridged model	31/03/2014	03/07/2014	29/07/2014	Dutch	PDF
Abridged model	31/03/2013	04/07/2013	16/09/2013	Dutch	PDF
Abridged model	31/03/2012	05/07/2012	01/10/2012	Dutch	PDF
Abridged model	31/03/2011	07/07/2011	21/10/2011	Dutch	PDF
Abridged model	31/03/2010	01/07/2010	19/08/2010	Dutch	PDF
Abridged model	31/03/2009	02/07/2009	22/09/2009	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 41 ended

Active mandates

Hille Van der Kaa

Director · since 25 juin 2025 · until 05 mars 2031

Active

Jacob Korteweg

Director · since 25 juin 2025 · until 05 mars 2031

Active

Niko Koffeman

Director · since 25 juin 2025 · until 05 mars 2031

Active

Ended mandates

Hille Van der Kaa

Director · since 20 mars 2020 · until 31 mars 2025

Ended

Hille Van der Kaa

Director · since 20 mars 2020 · until 06 juin 2025

Ended

Jacob Korteweg

Director · since 20 mars 2020 · until 31 mars 2025

Ended

Jacob Korteweg

Director · since 20 mars 2020 · until 06 juin 2025

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates25/01/2024
ONTSLAGEN - BENOEMINGEN
PDF
Other08/05/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING - ALGEMENE VERGADERING - BOEKJAAR
PDF
Mandates08/04/2020
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/03/2020
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/12/2017
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/10/2016
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/11/2014
ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/10/2014
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025145 k €↓
2024
Annual accounts 2024146 k €↑
2023
Annual accounts 2023116,8 k €↑
2022
Annual accounts 202296,5 k €↑
2021
Annual accounts 202173,1 k €↓
2019
Annual accounts 201991 k €↓
2018
Annual accounts 2018181,9 k €↓
2017
Annual accounts 2017184,2 k €↓
2016
Annual accounts 2016211,7 k €↑
2015
Annual accounts 2015201,1 k €↓
2014
Annual accounts 2014349,2 k €↑
2013
Annual accounts 2013315,8 k €↑
2012
Annual accounts 2012120,6 k €↑
2011
Annual accounts 201175,6 k €↑
2010
Annual accounts 201051 k €↑
2009
Annual accounts 200929,1 k €
20/03/2008
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

NewMilkLab

Overview

What does NewMilkLab do?

Trend over 16 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline